CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
We aimed to elucidate the diagnostic potential of the C-X-C motif chemokine receptor 4 (CXCR4)-directed positron emission tomography (PET) tracer 68Ga-Pentixafor in patients with poorly differentiated neuroendocrine carcinomas (NEC), relative to the established reference standard 18F-FDG PET/computed tomography (CT). In our database, we retrospecti...
Alternative Titles
Full title
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3a728236f82f4dfa8d4b95b497338943
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3a728236f82f4dfa8d4b95b497338943
Other Identifiers
ISSN
2075-4418
E-ISSN
2075-4418
DOI
10.3390/diagnostics11040605
